Cyril Dousson,David Dukhan,Christophe C. Parsy,Stephane L. Bogen
申请号：
US16462779
公开号：
US20190365788A1
申请日:
2017.11.15
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to Compounds of Formula (I) or Formula (II) or a pharmaceutically acceptable salt, solvate or enantiomer thereof, wherein A, B, R1, R2, R3, R4, Q and V are as defined herein. The present invention also relates to pharmaceutical compositions comprising a Compound of Formula (I) or Formula (II) and to their use in therapy.
